in these forward-looking statements are reasonable,
they do involve assumptions, risks and uncertainties, and these expectations
may prove to be incorrect. Investors should not place undue reliance on these
forward-looking statements, which speak only as of the date of this press
release. The Company's actual results could differ materially from those
anticipated in these forward-looking statements as a result of a variety of
factors, including those discussed in the Company's periodic reports that are
filed with the Securities and Exchange Commission and available on its website
(
http://www.sec.gov ). All forward-looking statements attributable to the
Company or persons acting on its behalf are expressly qualified in their
entirety by these factors. Other than as required under the securities laws,
the Company does not assume a duty to update these forward-looking statements.
CHINA BIOLOGIC PRODUCTS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME
FOR THE YEARS ENDED DECEMBER 31, 2008 AND 2007
2008 2007
REVENUES $46,751,160 $32,398,669
COST OF SALES 14,040,602 9,945,921
GROSS PROFIT 32,710,558 22,452,748
OPERATING EXPENSES:
Selling expenses 2,212,073 4,434,721
General and administrative
expenses 7,684,493 4,651,434
Research and development
expenses 1,166,494 609,178
Stock-based compensation
expenses (general and
administrative) 1,311,727 --
TOTAL OPERATING EXPENSES
'/>"/>
SOURCE China Biologic Products, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Related biology technology :1.
China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results2.
China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results3.
China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day4.
China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.5.
China Technology Announces New Chief Financial Officer6.
China Medical Technologies Reports First Quarter Financial Results7.
China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference8.
China Technology Announces Entry to the Solar Energy Sector9.
China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products10.
Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association11.
China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch